Vosjan MJ - Search Results

1

Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy.

Vosjan MJ, Vercammen J, Kolkman JA, Stigter-van Walsum M, Revets H, van Dongen GA. Vosjan MJ, et al. Mol Cancer Ther. 2012 Apr;11(4):1017-25. doi: 10.1158/1535-7163.MCT-11-0891. Epub 2012 Feb 7. Mol Cancer Ther. 2012. PMID: 22319202 Free article.

2

Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivo.

Maussang D, Mujić-Delić A, Descamps FJ, Stortelers C, Vanlandschoot P, Stigter-van Walsum M, Vischer HF, van Roy M, Vosjan M, Gonzalez-Pajuelo M, van Dongen GA, Merchiers P, van Rompaey P, Smit MJ. Maussang D, et al. Among authors: vosjan m. J Biol Chem. 2013 Oct 11;288(41):29562-72. doi: 10.1074/jbc.M113.498436. Epub 2013 Aug 26. J Biol Chem. 2013. PMID: 23979133 Free PMC article.

3

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

Verel I, Visser GW, Boerman OC, van Eerd JE, Finn R, Boellaard R, Vosjan MJ, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. Among authors: vosjan mj. Cancer Biother Radiopharm. 2003 Aug;18(4):655-61. doi: 10.1089/108497803322287745. Cancer Biother Radiopharm. 2003. PMID: 14503961

4

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

Perk LR, Visser GW, Vosjan MJ, Stigter-van Walsum M, Tijink BM, Leemans CR, van Dongen GA. Perk LR, et al. Among authors: vosjan mj. J Nucl Med. 2005 Nov;46(11):1898-906. J Nucl Med. 2005. PMID: 16269605 Free article.

5

Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.

Perk LR, Stigter-van Walsum M, Visser GW, Kloet RW, Vosjan MJ, Leemans CR, Giaccone G, Albano R, Comoglio PM, van Dongen GA. Perk LR, et al. Among authors: vosjan mj. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1857-67. doi: 10.1007/s00259-008-0774-5. Epub 2008 May 20. Eur J Nucl Med Mol Imaging. 2008. PMID: 18491091

6

Immuno-positron emission tomography: shedding light on clinical antibody therapy.

van Dongen GA, Vosjan MJ. van Dongen GA, et al. Among authors: vosjan mj. Cancer Biother Radiopharm. 2010 Aug;25(4):375-85. doi: 10.1089/cbr.2010.0812. Cancer Biother Radiopharm. 2010. PMID: 20707716 Review.

7

Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET.

Vosjan MJ, Perk LR, Roovers RC, Visser GW, Stigter-van Walsum M, van Bergen En Henegouwen PM, van Dongen GA. Vosjan MJ, et al. Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):753-63. doi: 10.1007/s00259-010-1700-1. Epub 2011 Jan 6. Eur J Nucl Med Mol Imaging. 2011. PMID: 21210114 Free PMC article.

8

Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.

Perk LR, Visser OJ, Stigter-van Walsum M, Vosjan MJ, Visser GW, Zijlstra JM, Huijgens PC, van Dongen GA. Perk LR, et al. Among authors: vosjan mj. Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1337-45. doi: 10.1007/s00259-006-0160-0. Epub 2006 Jul 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16832633

9

High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.

Verel I, Visser GW, Vosjan MJ, Finn R, Boellaard R, van Dongen GA. Verel I, et al. Among authors: vosjan mj. Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1645-52. doi: 10.1007/s00259-004-1632-8. Epub 2004 Jul 31. Eur J Nucl Med Mol Imaging. 2004. PMID: 15290121

10

Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.

Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA. Börjesson PK, et al. Among authors: vosjan mj. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2133-40. doi: 10.1158/1078-0432.CCR-05-2137. Clin Cancer Res. 2006. PMID: 16609026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page